Pathology and laboratory medicine.

Geradts, J; McLendon, W W · JAMA · 1994

review · Level V

Where this comes from

Abstract

Image analysis and flow cytometry are complementary methods in assessing the DNA content and proliferative capacity of a tumor. In prostatic adenocarcinomas, DNA aneuploidy is associated with poor outcome. The current 21 days for identification of mycobacteria and 28 days for susceptibility testing should be reduced in the coming years.

Medical subject headings